| Name | glucagon |
|---|---|
| Synonyms | GCG; GLP 1; GLP1; GLP 2; GLP2; GRPP; Glicentin related polypeptide; Glucagon… |
| Name | IAA |
|---|---|
| CAS |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 11200711 | Nazaimoon WM, Azmi KN, Rasat R, Ismail IS, Singaraveloo M, Mohamad WB, Letchuman R, Sheriff IH, Faridah I, Khalid BA: Autoimmune markers in young Malaysian patients with type 1 diabetes mellitus. Med J Malaysia. 2000 Sep;55(3):318-23. Venous blood was taken at fasting, and at 6 minutes post-glucagon (1 mg i.v.). |
2(0,0,0,2) | Details |
| 10200135 | Berberoglu M, Ocal G, Ikinciogullari A, Adiyaman P, Cetinkaya E, Tutar E, Babacan E: Evaluation of the pancreas reserve in siblings of type I diabetic children. Pediatr Int. 1999 Feb;41(1):42-5. For siblings of the diabetic children, fasting, post-prandial and glucagon response C-peptide mean values were 2.2 +/- 1.2, 7.2 +/- 7.1 and 5.3 +/- 3.6 ng/mL, respectively, while in the control group they were 1.5 +/- 0.8, 3.6 +/- 2.0 and 5.1 +/- 2.9 ng/mL, respectively. |
2(0,0,0,2) | Details |
| 12687930 | Szepietowska B, Szelachowska M, Gorska M, Stepien A, Kinalska I: [Clinical, biochemical and immunological characteristic of diabetes type I, LADA, diabetes type II, and MODY patients]. Pol Arch Med Wewn. 2002 Dec;108(6):1177-84. We measured basal and stimulated C-peptide (6 minutes after 1 mg i.v. glucagon) (ELISA) and antibodies titers to glutamic acid decarboxylase--antiGAD65, tyrosine phosphatase-like molecule--IA2 and insulin--IAA (RIA). |
1(0,0,0,1) | Details |
| 20061360 | Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, Childress RD, Craven TE, Cuddihy RM, Dailey G, Feinglos MN, Ismail-Beigi F, Largay JF, O'Connor PJ, Paul T, Savage PJ, Schubart UK, Sood A, Genuth S: The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. 2010 Jan 8;340:b5444. doi: 10.1136/bmj.b5444. MAIN OUTCOME MEASURES: Severe hypoglycaemia was defined as episodes of "low blood requiring the assistance of another person and documentation of either a plasma less than 2.8 mmol/l (<50 mg/dl) or symptoms that promptly resolved with oral carbohydrate, intravenous or glucagon. |
1(0,0,0,1) | Details |
| 9627364 | Barazzoni R, Zanetti M, Vettore M, Tessari P: Relationships between hydroxylation and plasma aromatic amino acid concentrations in humans. Metabolism. 1998 Jun;47(6):669-74. We investigated the relationships between hydroxylation Hy) and plasma concentrations of and glucagon in healthy male volunteers (N = 13; age, 29 +/- 3 years). |
1(0,0,0,1) | Details |
| 12482194 | Rolandsson O, Haney MF, Hagg E, Biber B, Lernmark A: Streptozotocin induced diabetes in minipig: a case report of a possible model for type 1 diabetes?. Autoimmunity. 2002 Jul;35(4):261-4. The pathoanatomical examination showed atrophy of the beta-cell population, depletion of insulin with preserved glucagon content. |
1(0,0,0,1) | Details |
| 10937518 | Betterle C, Fabris P, Zanchetta R, Pedini B, Tositti G, Bosi E, de Lalla F: Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection. Diabetes Care. 2000 Aug;23(8):1177-81. Autoantibodies to islet cell (ICA), glucagon-producing cells (GCA), parietal cell (PCA), adrenal cortex (ACA), adrenal medulla (AdMA), nuclei (ANA), liver-kidney microsomal (LKM-Ab), mitochondrial, and smooth muscle (SMA) were tested using the classic indirect immunofluorescence technique. |
1(0,0,0,1) | Details |
| 16832790 | Szepietowska B, Szelachowska M, Gorska M: [Family incidence of latent autoimmune diabetes in adults--case report] . Endokrynol Pol. 2006 May-Jun;57(3):254-7. However plasma level of C peptide basal and after stimulation with glucagon was reduced. |
1(0,0,0,1) | Details |
| 12605834 | Aguilera E, Recasens M, Morinigo RA, Casamitjana R, Oriola J, Ercilla G, Conget I: [Clinical, metabolic, immunologic and genotypic characteristics in non-pediatric patients with type 1A diabetes mellitus. Med Clin. 2003 Feb 8;120(4):121-4. Pancreatic cell function was assessed by glucagon test (at onset and at 12 months). |
1(0,0,0,1) | Details |